Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders.
about
Menopause, obesity and inflammation: interactive risk factors for Alzheimer's diseaseUnderstanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profileRosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III studyInsulin: an emerging treatment for Alzheimer's disease dementia?Link between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatmentEpidemiology of Alzheimer diseaseAMPK: a cellular metabolic and redox sensor. A minireviewBeyond fast food and slow motion: weighty contributors to the obesity epidemicBrain insulin resistance in Alzheimer's disease and its potential treatment with GLP-1 analogsThe restorative role of annexin A1 at the blood-brain barrier.Cohort profile: the Finnish Medication and Alzheimer's disease (MEDALZ) studyEnergy intake and exercise as determinants of brain health and vulnerability to injury and diseasePathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesisUsing Multicountry Ecological and Observational Studies to Determine Dietary Risk Factors for Alzheimer's Disease.An application of Pavlovian principles to the problems of obesity and cognitive declineDance Experience and Associations with Cortical Gray Matter Thickness in the Aging PopulationUse of existing data sources in clinical epidemiology: Finnish health care registers in Alzheimer's disease research - the Medication use among persons with Alzheimer's disease (MEDALZ-2005) studyAlzheimer's Disease in Down Syndrome.Longitudinal Relationships between Caloric Expenditure and Gray Matter in the Cardiovascular Health Study.Molecular approaches in obesity studiesThe nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease.Cognitive impairment in diabetic patients: Can diabetic control prevent cognitive decline?Diabetes mellitus and risk of dementia: A meta-analysis of prospective observational studies.High-fat diet-induced memory impairment in triple-transgenic Alzheimer's disease (3xTgAD) mice is independent of changes in amyloid and tau pathology.Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitusModifiable risk factors for Alzheimer disease and subjective memory impairment across age groups.Maternal high-fat diet worsens memory deficits in the triple-transgenic (3xTgAD) mouse model of Alzheimer's disease.Genetic architecture of epigenetic and neuronal ageing rates in human brain regions.Age-dependent regulation of obesity and Alzheimer-related outcomes by hormone therapy in female 3xTg-AD mice.Obesity Accelerates Alzheimer-Related Pathology in APOE4 but not APOE3 Mice.High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice.Interaction Between Midlife Blood Glucose and APOE Genotype Predicts Later Alzheimer's Disease Pathology.Epidemiology of dementia in Central Africa (EPIDEMCA): protocol for a multicentre population-based study in rural and urban areas of the Central African Republic and the Republic of Congo.The association of duration of type 2 diabetes with cognitive performance is modulated by long-term glycemic controlPlasma clusterin (ApoJ) levels are associated with adiposity and systemic inflammation.Is Alzheimer's disease a systemic disease?Amyloid precursor protein and proinflammatory changes are regulated in brain and adipose tissue in a murine model of high fat diet-induced obesity.Human cognitive function and the obesogenic environment.Current and emerging drug treatment options for Alzheimer's disease: a systematic review.Longitudinal effects of metabolic syndrome on Alzheimer and vascular related brain pathology.
P2860
Q21131065-6784C065-FBAD-4E54-B97B-F838EECDC381Q21245293-A661F6CF-32EF-40AA-8979-B48996E8124EQ24628969-2A65A50B-62E6-449C-9EFE-DB7A3E3065A1Q26827376-766251E2-5DFD-4A57-8898-C9B88F9FDD80Q26860246-49FE6413-3138-4631-A102-7650DDC5B607Q26865371-B7A51E4E-B987-45D0-B6DE-63A37B32C50CQ26995682-A99E6629-EA16-4115-AD7E-11F47742F97DQ27001046-88F6DA8A-3D4B-48FA-9246-F9D8C1BA900FQ27012801-B66FCF04-C63A-48F3-A467-52FFCEA84C93Q27687514-0DA5FACA-C9AD-48E6-B4EA-0C5193AB8488Q28384359-67BE702F-D25D-4FD4-9E47-A993326B1B3CQ28710367-BB1A1834-ED6E-4C6C-A10D-60D8A0A2B66FQ30235369-B80F2911-DC9B-4E76-839C-C7D6C3C9A126Q30248800-5CC9EB2A-7E0D-49FB-8EE9-CE6EFF8E26BAQ30352343-96A76732-3ED8-4D72-902B-2FCC1824B670Q30396059-682C00F0-B983-4364-8745-26F823248BB2Q30661806-4F745061-5D14-43C1-9986-DD8228BD9598Q30857550-6DC48FD8-013A-4D3E-A70E-94A17102D917Q31056938-9426E05B-3C72-4C07-9A63-E2B56DF70FAEQ33596708-6795460E-0FA7-4412-A7CA-412C280EB867Q33600053-48AFD308-1D68-4B99-96D6-A2D290FB9D53Q33603286-EF20C541-BC6E-4577-A1B0-0AEF227C24A0Q33607787-A31F382B-F071-482E-AFF2-E5A36F542EC4Q33624475-42BF6590-7463-433F-96BD-5C79F81F063AQ33699361-FD90F916-763F-4A49-99E7-162AAFDA57C2Q33712358-8DD6B207-C65D-4EC4-8BF7-D06AB1F67E4CQ33740362-1A565B8C-AF81-4683-BCB4-9AB3C6F293C5Q33753774-B504A02D-C7E2-4DC2-89DD-4744B2AD44C0Q33757617-381D10C2-7C76-46D6-A79B-9FFE1591E558Q33791780-17299551-5D64-4AA6-8560-A827A644A8B0Q33850466-FC42E31E-F114-48A0-9A3A-4A208145DE54Q33862866-3397060E-D6BC-4173-A5E5-C63A5A0263E1Q33897058-A76E3865-FFF4-46FE-BD69-05D58AF4B056Q33940847-2BEB69D0-A1CD-48BB-975F-9FDC4F75CBDDQ33975263-8460CA33-18B8-4BD2-80DC-AC869DB850B0Q34019193-35B2B6E6-5DD9-4714-A766-6C233A3941F8Q34140538-47930F24-7029-421C-9465-763978C6973FQ34167761-E5A79C89-D249-4308-AA39-663D10AFFF34Q34222721-092DDC26-EFE8-416A-8A0B-E523DA7D3444Q34296138-39AA72DF-FEBC-433A-9E0E-24F36B86F1A4
P2860
Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders.
@en
Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders.
@nl
type
label
Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders.
@en
Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders.
@nl
prefLabel
Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders.
@en
Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders.
@nl
P921
P1476
Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders.
@en
P2093
Anton P Porsteinsson
Louis A Profenno
P304
P356
10.1016/J.BIOPSYCH.2009.02.013
P407
P577
2009-04-09T00:00:00Z